The optimal endoscopic screening interval for detecting early gastric neoplasms.

BACKGROUND The optimal interval between endoscopic examinations for detecting early gastric neoplasms, including gastric adenomas, has not previously been studied. OBJECTIVE To clarify the optimal interval between endoscopic examinations for the early diagnosis of both gastric cancers and adenomas. DESIGN Retrospective study. SETTING University-affiliated tertiary-care hospital, Seoul, Korea. PATIENTS Patients who were treated for gastric neoplasms between January 2008 and August 2013. INTERVENTIONS Questionnaire survey for interval between the penultimate endoscopy and diagnosis of a gastric neoplasm. A total of 846 patients were divided into 5 groups according to the interval between endoscopic examinations. MAIN OUTCOME MEASUREMENTS The proportion of gastric neoplasms treated with endoscopic submucosal dissection and the proportion of advanced gastric cancers according to the interval between endoscopic examinations. RESULTS In total, 197, 430, and 219 patients were diagnosed with gastric adenoma, early gastric cancer, and advanced gastric cancer, respectively. In multivariate analysis, the proportion of gastric neoplasms treated with endoscopic submucosal dissection was significantly higher in the ≤12 months, 12 to 24 months, and 24 to 36 months endoscopy interval groups than in the no endoscopy within 5 years group (all P < .001). In addition, the proportion of advanced gastric cancers was significantly lower in the ≤12 months and 12 to 24 months endoscopy interval groups than in the no endoscopy within 5 years group (all P < .001). LIMITATIONS Retrospective study and recall bias. CONCLUSION Annual endoscopy cannot facilitate the detection of endoscopically treatable gastric neoplasms compared with biennial or triennial endoscopy. We recommend biennial endoscopic screening for gastric neoplasms in order to increase the proportion of lesions discovered while they are still endoscopically treatable and to reduce the number of lesions that progress to advanced gastric cancer.

[1]  Seonwoo Kim,et al.  Survival Outcome Associated with the Screening Interval for Gastric Cancer in Korea , 2011, Digestion.

[2]  S. Shin,et al.  Sedation methods can determine performance of endoscopic submucosal dissection in patients with gastric neoplasia , 2013, Surgical Endoscopy.

[3]  S. Shirahama,et al.  Results of mass endoscopic examination for gastric cancer in Kamigoto Hospital, Nagasaki Prefecture. , 2007, World journal of gastroenterology.

[4]  M. Gail,et al.  No impact of repeated endoscopic screens on gastric cancer mortality in a prospectively followed Chinese population at high risk. , 2002, Preventive medicine.

[5]  M. S. Lee,et al.  Efficacy of screening for gastric cancer in a Korean adult population: a case-control study. , 2000, Journal of Korean medical science.

[6]  M. Rugge,et al.  Gastric epithelial dysplasia. How clinicopathologic background relates to management , 1995, Cancer.

[7]  B. Warren,et al.  Quality control in upper gastrointestinal endoscopy: detection rates of gastric cancer in Oxford 2005–2008 , 2011, Postgraduate Medical Journal.

[8]  R. Soetikno,et al.  Endoscopic submucosal dissection of early gastric cancer , 2006, Journal of Gastroenterology.

[9]  유희철.  간담췌 종양에 대한 American Joint Committee on Cancer (AJCC) 종양 병기 7판 소개 , 2010 .

[10]  Takanori Yoshida,et al.  Effect of periodic endoscopy for gastric cancer on early detection and improvement of survival , 2001, Gastric Cancer.

[11]  A. Jemal,et al.  Global Cancer Statistics , 2011 .

[12]  M F Dixon,et al.  High grade dysplasia of the gastric mucosa: a marker for gastric carcinoma. , 1990, Gut.

[13]  H. Jung,et al.  Effect of annual endoscopic screening on clinicopathologic characteristics and treatment modality of gastric cancer in a high‐incidence region of Korea , 2012, International journal of cancer.

[14]  J. Siewert,et al.  Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study. , 1998, Annals of surgery.

[15]  K. Ohta,et al.  Chronological changes of characteristics of early gastric cancer and therapy: Experience in the Cancer Institute Hospital of Tokyo, 1950–1994 , 2005, Journal of Cancer Research and Clinical Oncology.

[16]  C. Compton,et al.  AJCC Cancer Staging Manual , 2002, Springer New York.

[17]  A. Oshima,et al.  Natural history of early gastric cancer: a non-concurrent, long term, follow up study , 2000, Gut.

[18]  Toshiharu Yamaguchi,et al.  Natural history of gastric cancer—a case followed up for eight years: early to advanced gastric cancer , 2012, Clinical Journal of Gastroenterology.

[19]  Tomotaka Sobue,et al.  The Japanese guidelines for gastric cancer screening. , 2008, Japanese journal of clinical oncology.

[20]  T. Saito,et al.  Significant prognostic factors in patients with early gastric cancer. , 2000, International surgery.

[21]  I. Choi,et al.  Effect of repeated endoscopic screening on the incidence and treatment of gastric cancer in health screenees , 2009, European journal of gastroenterology & hepatology.

[22]  M. Jung,et al.  Long-term follow-up study of gastric intraepithelial neoplasias: progression from low-grade dysplasia to invasive carcinoma , 2008, European journal of gastroenterology & hepatology.

[23]  H. Lee,et al.  Gastric cancer in Korea , 2002, Gastric Cancer.

[24]  A. Sigurdsson,et al.  The long term results of endoscopic surveillance of premalignant gastric lesions , 2002, Gut.

[25]  Japanese Gastric Cancer Association.  Japanese classification of gastric carcinoma: 3rd English edition , 2011, Gastric Cancer.